$CTIC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CTI BIOPHARMA CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in CTI BIOPHARMA CORP. Get notifications about new insider transactions in CTI BIOPHARMA CORP for free.
Page: < prev 1 2 3 4 5 6 ... 13 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 27 2017 | CTIC | CTI BIOPHARMA CORP | NUDELMAN PHILLIP M PHD | Director | Option Exercise | A | 4.25 | 50,000 | 212,500 | 50,000 | |
Feb 27 2017 | CTIC | CTI BIOPHARMA CORP | Metzger Michael A | Director | Option Exercise | A | 4.25 | 50,000 | 212,500 | 50,000 | |
Jan 24 2017 | CTIC | CTI BIOPHARMA CORP | Metzger Michael A | Director | Option Exercise | A | 0.00 | 20,121 | 0 | 20,121 | |
Jan 13 2017 | CTIC | CTI BIOPHARMA CORP | PERRY MATTHEW D | Director | Option Exercise | M | 0.00 | 8,403 | 0 | 0 | |
Jan 13 2017 | CTIC | CTI BIOPHARMA CORP | PERRY MATTHEW D | Director | Buy | M | 0.00 | 8,403 | 0 | 8,403 | 0 to 8.4 K |
Jan 03 2017 | CTIC | CTI BIOPHARMA CORP | SEELEY BRUCE J. | EVP, Chief Commerci ... | Grant | A | 0.30 | 5,000 | 1,523 | 310,000 | 305 K to 310 K (+1.64 %) |
Oct 24 2016 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Interim CEO and Pre ... | Option Exercise | A | 0.41 | 500,000 | 204,350 | 500,000 | |
Oct 24 2016 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Interim CEO and Pre ... | Option Exercise | A | 0.41 | 500,000 | 204,350 | 500,000 | |
Oct 03 2016 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | Director | Option Exercise | A | 0.37 | 4,539,290 | 1,699,056 | 4,539,290 | |
Oct 03 2016 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | Director | Option Exercise | A | 1.10 | 2,000,000 | 2,200,000 | 2,000,000 | |
Jul 01 2016 | CTIC | CTI BIOPHARMA CORP | SEELEY BRUCE J. | EVP, Chief Commerci ... | Grant | A | 0.29 | 5,000 | 1,445 | 305,000 | 300 K to 305 K (+1.67 %) |
Jun 24 2016 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | President and CEO | Sell | S | 0.37 | 10,000 | 3,654 | 1,780,133 | 1.8 M to 1.8 M (-0.56 %) |
May 27 2016 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | President and CEO | Sell | S | 0.45 | 10,000 | 4,471 | 1,790,133 | 1.8 M to 1.8 M (-0.56 %) |
May 20 2016 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | President and CEO | Option Exercise | A | 0.45 | 600,000 | 268,500 | 600,000 | |
May 03 2016 | CTIC | CTI BIOPHARMA CORP | PERRY MATTHEW D | Director | Option Exercise | A | 0.00 | 347,360 | 0 | 431,394 | |
Apr 29 2016 | CTIC | CTI BIOPHARMA CORP | Tuckson Reed Vaughn | Director | Option Exercise | A | 0.00 | 347,360 | 0 | 347,360 | |
Apr 29 2016 | CTIC | CTI BIOPHARMA CORP | Tuckson Reed Vaughn | Director | Option Exercise | M | 0.00 | 63,695 | 0 | 0 | |
Apr 29 2016 | CTIC | CTI BIOPHARMA CORP | Tuckson Reed Vaughn | Director | Buy | M | 0.00 | 63,695 | 0 | 576,881 | 513.2 K to 576.9 K (+12.41 %) |
Apr 29 2016 | CTIC | CTI BIOPHARMA CORP | Telling Fred | Director | Option Exercise | A | 0.00 | 347,360 | 0 | 347,360 | |
Apr 29 2016 | CTIC | CTI BIOPHARMA CORP | Telling Fred | Director | Option Exercise | M | 0.00 | 63,695 | 0 | 0 | |
Apr 29 2016 | CTIC | CTI BIOPHARMA CORP | Telling Fred | Director | Buy | M | 0.00 | 63,695 | 0 | 441,389 | 377.7 K to 441.4 K (+16.86 %) |
Apr 29 2016 | CTIC | CTI BIOPHARMA CORP | NUDELMAN PHILLIP M PHD | Director | Option Exercise | A | 0.00 | 396,983 | 0 | 396,983 | |
Apr 29 2016 | CTIC | CTI BIOPHARMA CORP | NUDELMAN PHILLIP M PHD | Director | Option Exercise | M | 0.00 | 79,618 | 0 | 0 | |
Apr 29 2016 | CTIC | CTI BIOPHARMA CORP | NUDELMAN PHILLIP M PHD | Director | Buy | M | 0.00 | 79,618 | 0 | 334,311 | 254.7 K to 334.3 K (+31.26 %) |
Apr 29 2016 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Option Exercise | A | 0.00 | 347,360 | 0 | 347,360 | |
Apr 29 2016 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Option Exercise | M | 0.00 | 63,695 | 0 | 0 | |
Apr 29 2016 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Buy | M | 0.00 | 63,695 | 0 | 535,824 | 472.1 K to 535.8 K (+13.49 %) |
Apr 29 2016 | CTIC | CTI BIOPHARMA CORP | MUNDINGER MARY ONEIL | Director | Option Exercise | M | 0.00 | 63,695 | 0 | 0 | |
Apr 29 2016 | CTIC | CTI BIOPHARMA CORP | MUNDINGER MARY ONEIL | Director | Buy | M | 0.00 | 63,695 | 0 | 360,019 | 296.3 K to 360 K (+21.50 %) |
Apr 29 2016 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | President and CEO | Sell | S | 0.52 | 10,000 | 5,162 | 1,800,133 | 1.8 M to 1.8 M (-0.55 %) |
Mar 30 2016 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | President and CEO | Sell | S | 0.49 | 10,000 | 4,941 | 1,810,133 | 1.8 M to 1.8 M (-0.55 %) |
Mar 23 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Payment of Exercise | F | 0.55 | 63,874 | 35,016 | 526,210 | 590.1 K to 526.2 K (-10.82 %) |
Mar 23 2016 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Payment of Exercise | F | 0.55 | 46,556 | 25,522 | 622,933 | 669.5 K to 622.9 K (-6.95 %) |
Mar 23 2016 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Scientif ... | Payment of Exercise | F | 0.55 | 45,935 | 25,182 | 994,057 | 1 M to 994.1 K (-4.42 %) |
Mar 23 2016 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | President and CEO | Sell | S | 0.55 | 318,169 | 174,866 | 1,820,133 | 2.1 M to 1.8 M (-14.88 %) |
Mar 04 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 0.60 | 900 | 536 | 590,084 | 591 K to 590.1 K (-0.15 %) |
Mar 04 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 0.60 | 1,220 | 726 | 590,984 | 592.2 K to 591 K (-0.21 %) |
Mar 04 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 0.59 | 500 | 297 | 592,204 | 592.7 K to 592.2 K (-0.08 %) |
Mar 04 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 0.59 | 1,100 | 652 | 592,704 | 593.8 K to 592.7 K (-0.19 %) |
Mar 04 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 0.59 | 200 | 118 | 593,804 | 594 K to 593.8 K (-0.03 %) |
Mar 04 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 0.59 | 700 | 414 | 594,004 | 594.7 K to 594 K (-0.12 %) |
Mar 04 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 0.59 | 700 | 413 | 594,704 | 595.4 K to 594.7 K (-0.12 %) |
Mar 04 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 0.59 | 844 | 497 | 595,404 | 596.2 K to 595.4 K (-0.14 %) |
Mar 04 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 0.59 | 1,500 | 882 | 596,248 | 597.7 K to 596.2 K (-0.25 %) |
Mar 04 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 0.59 | 636 | 373 | 597,748 | 598.4 K to 597.7 K (-0.11 %) |
Mar 04 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 0.59 | 400 | 234 | 598,384 | 598.8 K to 598.4 K (-0.07 %) |
Mar 04 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 0.59 | 1,300 | 761 | 598,784 | 600.1 K to 598.8 K (-0.22 %) |
Feb 26 2016 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | President and CEO | Sell | S | 0.63 | 10,000 | 6,294 | 2,138,302 | 2.1 M to 2.1 M (-0.47 %) |
Feb 26 2016 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Scientif ... | Sell | S | 0.64 | 500 | 322 | 1,039,992 | 1 M to 1 M (-0.05 %) |
Feb 26 2016 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Scientif ... | Sell | S | 0.64 | 100 | 64 | 1,040,492 | 1 M to 1 M (-0.01 %) |
Feb 26 2016 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Scientif ... | Sell | S | 0.64 | 200 | 128 | 1,040,592 | 1 M to 1 M (-0.02 %) |
Feb 26 2016 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Scientif ... | Sell | S | 0.64 | 3,270 | 2,086 | 1,040,792 | 1 M to 1 M (-0.31 %) |
Feb 26 2016 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Scientif ... | Sell | S | 0.64 | 2,600 | 1,656 | 1,044,062 | 1 M to 1 M (-0.25 %) |
Feb 26 2016 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Scientif ... | Sell | S | 0.64 | 1,130 | 719 | 1,046,662 | 1 M to 1 M (-0.11 %) |
Feb 26 2016 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Scientif ... | Sell | S | 0.64 | 600 | 381 | 1,047,792 | 1 M to 1 M (-0.06 %) |
Feb 26 2016 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Scientif ... | Sell | S | 0.63 | 3,990 | 2,530 | 1,048,392 | 1.1 M to 1 M (-0.38 %) |
Feb 26 2016 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Scientif ... | Sell | S | 0.63 | 600 | 380 | 1,052,382 | 1.1 M to 1.1 M (-0.06 %) |
Feb 26 2016 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Scientif ... | Sell | S | 0.63 | 100 | 63 | 1,052,982 | 1.1 M to 1.1 M (-0.01 %) |
Feb 26 2016 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Scientif ... | Sell | S | 0.63 | 300 | 189 | 1,053,082 | 1.1 M to 1.1 M (-0.03 %) |
Feb 26 2016 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Scientif ... | Sell | S | 0.63 | 200 | 125 | 1,053,382 | 1.1 M to 1.1 M (-0.02 %) |
Feb 26 2016 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Scientif ... | Sell | S | 0.62 | 200 | 125 | 1,053,582 | 1.1 M to 1.1 M (-0.02 %) |
Feb 26 2016 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Scientif ... | Sell | S | 0.62 | 100 | 62 | 1,053,782 | 1.1 M to 1.1 M (-0.01 %) |
Feb 26 2016 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Scientif ... | Sell | S | 0.62 | 510 | 317 | 1,053,882 | 1.1 M to 1.1 M (-0.05 %) |
Feb 26 2016 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Scientif ... | Sell | S | 0.62 | 200 | 124 | 1,054,392 | 1.1 M to 1.1 M (-0.02 %) |
Feb 26 2016 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Scientif ... | Sell | S | 0.62 | 300 | 185 | 1,054,592 | 1.1 M to 1.1 M (-0.03 %) |
Feb 26 2016 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Scientif ... | Sell | S | 0.62 | 100 | 62 | 1,054,892 | 1.1 M to 1.1 M (-0.01 %) |
Feb 18 2016 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | President and CEO | Sell | S | 0.42 | 100,000 | 41,920 | 2,148,302 | 2.2 M to 2.1 M (-4.45 %) |
Feb 05 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 1.18 | 300 | 353 | 600,084 | 600.4 K to 600.1 K (-0.05 %) |
Feb 05 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 1.17 | 700 | 819 | 600,384 | 601.1 K to 600.4 K (-0.12 %) |
Feb 05 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 1.16 | 600 | 696 | 601,084 | 601.7 K to 601.1 K (-0.10 %) |
Feb 05 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 1.16 | 3,000 | 3,465 | 601,684 | 604.7 K to 601.7 K (-0.50 %) |
Feb 05 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 1.15 | 5,000 | 5,750 | 604,684 | 609.7 K to 604.7 K (-0.82 %) |
Feb 05 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 1.14 | 400 | 456 | 609,684 | 610.1 K to 609.7 K (-0.07 %) |
Jan 29 2016 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | President and CEO | Sell | S | 1.20 | 10,000 | 12,012 | 2,248,302 | 2.3 M to 2.2 M (-0.44 %) |
Jan 29 2016 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Scientif ... | Sell | S | 1.20 | 2,600 | 3,120 | 1,054,992 | 1.1 M to 1.1 M (-0.25 %) |
Jan 29 2016 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Scientif ... | Sell | S | 1.20 | 300 | 359 | 1,057,592 | 1.1 M to 1.1 M (-0.03 %) |
Jan 29 2016 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Scientif ... | Sell | S | 1.19 | 1,800 | 2,142 | 1,057,892 | 1.1 M to 1.1 M (-0.17 %) |
Jan 29 2016 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Scientif ... | Sell | S | 1.19 | 2,000 | 2,370 | 1,059,692 | 1.1 M to 1.1 M (-0.19 %) |
Jan 29 2016 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Scientif ... | Sell | S | 1.18 | 2,500 | 2,950 | 1,061,692 | 1.1 M to 1.1 M (-0.23 %) |
Jan 29 2016 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Scientif ... | Sell | S | 1.18 | 700 | 823 | 1,064,192 | 1.1 M to 1.1 M (-0.07 %) |
Jan 29 2016 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Scientif ... | Sell | S | 1.17 | 5,100 | 5,967 | 1,064,892 | 1.1 M to 1.1 M (-0.48 %) |
Jan 13 2016 | CTIC | CTI BIOPHARMA CORP | PERRY MATTHEW D | Director | Option Exercise | A | 0.00 | 84,034 | 0 | 84,034 | |
Jan 11 2016 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.22 | 58,613 | 71,338 | 17,263,200 | 17.2 M to 17.3 M (+0.34 %) |
Jan 11 2016 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.22 | 32,571 | 39,642 | 3,090,744 | 3.1 M to 3.1 M (+1.07 %) |
Jan 11 2016 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.22 | 90,049 | 109,599 | 8,850,836 | 8.8 M to 8.9 M (+1.03 %) |
Jan 11 2016 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.22 | 186,314 | 226,763 | 15,592,160 | 15.4 M to 15.6 M (+1.21 %) |
Jan 11 2016 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.22 | 8,091 | 9,848 | 17,204,587 | 17.2 M to 17.2 M (+0.05 %) |
Jan 11 2016 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.22 | 29,655 | 36,093 | 3,058,173 | 3 M to 3.1 M (+0.98 %) |
Jan 11 2016 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.22 | 87,747 | 106,797 | 8,760,787 | 8.7 M to 8.8 M (+1.01 %) |
Jan 11 2016 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.22 | 508,287 | 618,636 | 15,405,846 | 14.9 M to 15.4 M (+3.41 %) |
Jan 08 2016 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | President and CEO | Option Exercise | A | 1.20 | 2,700,000 | 3,240,000 | 2,700,000 | |
Jan 06 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 1.26 | 200 | 252 | 610,084 | 610.3 K to 610.1 K (-0.03 %) |
Jan 06 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 1.25 | 600 | 750 | 610,284 | 610.9 K to 610.3 K (-0.10 %) |
Jan 06 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 1.24 | 202 | 250 | 610,884 | 611.1 K to 610.9 K (-0.03 %) |
Jan 06 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 1.24 | 300 | 371 | 611,086 | 611.4 K to 611.1 K (-0.05 %) |
Jan 06 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 1.23 | 800 | 984 | 611,386 | 612.2 K to 611.4 K (-0.13 %) |
Jan 06 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 1.22 | 1,700 | 2,074 | 612,186 | 613.9 K to 612.2 K (-0.28 %) |
Jan 06 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 1.21 | 1,900 | 2,299 | 613,886 | 615.8 K to 613.9 K (-0.31 %) |
Jan 06 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 1.21 | 800 | 964 | 615,786 | 616.6 K to 615.8 K (-0.13 %) |
Jan 06 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 1.20 | 1,898 | 2,278 | 616,586 | 618.5 K to 616.6 K (-0.31 %) |
Jan 06 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 1.20 | 1,600 | 1,912 | 618,484 | 620.1 K to 618.5 K (-0.26 %) |
Dec 31 2015 | CTIC | CTI BIOPHARMA CORP | NUDELMAN PHILLIP M PHD | Director | Option Exercise | A | 1.27 | 100,000 | 127,000 | 100,000 | |
Dec 31 2015 | CTIC | CTI BIOPHARMA CORP | Tuckson Reed Vaughn | Director | Option Exercise | A | 1.27 | 100,000 | 127,000 | 100,000 | |
Dec 31 2015 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Option Exercise | A | 1.27 | 100,000 | 127,000 | 100,000 | |
Dec 31 2015 | CTIC | CTI BIOPHARMA CORP | MUNDINGER MARY ONEIL | Director | Option Exercise | A | 1.27 | 100,000 | 127,000 | 100,000 | |
Dec 31 2015 | CTIC | CTI BIOPHARMA CORP | Telling Fred | Director | Option Exercise | A | 1.27 | 100,000 | 127,000 | 100,000 | |
Dec 30 2015 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | President and CEO | Sell | S | 1.26 | 100,000 | 125,710 | 2,258,302 | 2.4 M to 2.3 M (-4.24 %) |
Dec 30 2015 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | President and CEO | Sell | S | 1.29 | 10,000 | 12,921 | 2,358,302 | 2.4 M to 2.4 M (-0.42 %) |
Dec 23 2015 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Option Exercise | A | 1.24 | 1,600,000 | 1,984,000 | 1,600,000 | |
Dec 23 2015 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Sell | D | 0.00 | 236,858 | 0 | 669,489 | 906.3 K to 669.5 K (-26.13 %) |
Dec 23 2015 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | President and CEO | Option Exercise | A | 1.24 | 6,000,000 | 7,440,000 | 6,000,000 | |
Dec 23 2015 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | President and CEO | Sell | D | 0.00 | 583,217 | 0 | 2,368,302 | 3 M to 2.4 M (-19.76 %) |
Dec 23 2015 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Scientif ... | Option Exercise | A | 1.24 | 1,900,000 | 2,356,000 | 1,900,000 | |
Dec 23 2015 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Scientif ... | Sell | D | 0.00 | 236,858 | 0 | 1,069,992 | 1.3 M to 1.1 M (-18.12 %) |
Dec 23 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Option Exercise | A | 1.24 | 1,400,000 | 1,736,000 | 1,400,000 | |
Dec 23 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Option Exercise | D | 0.00 | 253,438 | 0 | 0 | |
Dec 23 2015 | CTIC | CTI BIOPHARMA CORP | SEELEY BRUCE J. | EVP, Chief Commerci ... | Option Exercise | A | 1.24 | 1,100,000 | 1,364,000 | 1,100,000 | |
Dec 23 2015 | CTIC | CTI BIOPHARMA CORP | SEELEY BRUCE J. | EVP, Chief Commerci ... | Option Exercise | D | 0.00 | 406,483 | 0 | 0 | |
Dec 18 2015 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP Global Medical ... | Sell | S | 1.19 | 400 | 474 | 1,306,850 | 1.3 M to 1.3 M (-0.03 %) |
Dec 18 2015 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP Global Medical ... | Sell | S | 1.18 | 10,696 | 12,621 | 1,307,250 | 1.3 M to 1.3 M (-0.81 %) |
Dec 18 2015 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP Global Medical ... | Sell | S | 1.18 | 2,000 | 2,350 | 1,317,946 | 1.3 M to 1.3 M (-0.15 %) |
Dec 18 2015 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP Global Medical ... | Sell | S | 1.17 | 1,904 | 2,228 | 1,319,946 | 1.3 M to 1.3 M (-0.14 %) |
Dec 11 2015 | CTIC | CTI BIOPHARMA CORP | Tuckson Reed Vaughn | Director | Sell | D | 0.00 | 58,320 | 0 | 513,186 | 571.5 K to 513.2 K (-10.20 %) |
Dec 11 2015 | CTIC | CTI BIOPHARMA CORP | Telling Fred | Director | Sell | D | 0.00 | 58,320 | 0 | 377,694 | 436 K to 377.7 K (-13.38 %) |
Dec 11 2015 | CTIC | CTI BIOPHARMA CORP | NUDELMAN PHILLIP M PHD | Director | Sell | D | 0.00 | 87,481 | 0 | 254,693 | 342.2 K to 254.7 K (-25.57 %) |
Dec 11 2015 | CTIC | CTI BIOPHARMA CORP | MUNDINGER MARY ONEIL | Director | Sell | D | 0.00 | 58,320 | 0 | 296,324 | 354.6 K to 296.3 K (-16.44 %) |
Dec 11 2015 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Sell | D | 0.00 | 58,320 | 0 | 472,129 | 530.4 K to 472.1 K (-10.99 %) |
Dec 04 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 1.01 | 200 | 202 | 620,084 | 620.3 K to 620.1 K (-0.03 %) |
Dec 04 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 1.01 | 100 | 101 | 620,284 | 620.4 K to 620.3 K (-0.02 %) |
Dec 04 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 1.00 | 4,500 | 4,500 | 620,384 | 624.9 K to 620.4 K (-0.72 %) |
Dec 04 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 1.00 | 100 | 100 | 624,884 | 625 K to 624.9 K (-0.02 %) |
Dec 04 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 1.00 | 200 | 200 | 624,984 | 625.2 K to 625 K (-0.03 %) |
Dec 04 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 1.00 | 300 | 300 | 625,184 | 625.5 K to 625.2 K (-0.05 %) |
Dec 04 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 1.00 | 100 | 100 | 625,484 | 625.6 K to 625.5 K (-0.02 %) |
Dec 04 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 1.00 | 100 | 100 | 625,584 | 625.7 K to 625.6 K (-0.02 %) |
Dec 04 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 1.00 | 600 | 597 | 625,684 | 626.3 K to 625.7 K (-0.10 %) |
Dec 04 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 0.99 | 200 | 199 | 626,284 | 626.5 K to 626.3 K (-0.03 %) |
Dec 04 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 0.99 | 1,100 | 1,094 | 626,484 | 627.6 K to 626.5 K (-0.18 %) |
Dec 04 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 0.99 | 200 | 199 | 627,584 | 627.8 K to 627.6 K (-0.03 %) |
Dec 04 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 0.99 | 200 | 198 | 627,784 | 628 K to 627.8 K (-0.03 %) |
Dec 04 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 0.99 | 600 | 594 | 627,984 | 628.6 K to 628 K (-0.10 %) |
Dec 04 2015 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 0.99 | 1,500 | 1,485 | 628,584 | 630.1 K to 628.6 K (-0.24 %) |
Nov 30 2015 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | President and CEO | Sell | S | 1.23 | 10,000 | 12,253 | 2,951,519 | 3 M to 3 M (-0.34 %) |
Nov 30 2015 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Global Medical ... | Sell | S | 1.22 | 3,295 | 4,020 | 1,321,850 | 1.3 M to 1.3 M (-0.25 %) |
Nov 30 2015 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Global Medical ... | Sell | S | 1.22 | 624 | 758 | 1,325,145 | 1.3 M to 1.3 M (-0.05 %) |
Nov 30 2015 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Global Medical ... | Sell | S | 1.21 | 7,781 | 9,415 | 1,325,769 | 1.3 M to 1.3 M (-0.58 %) |
Nov 30 2015 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Global Medical ... | Sell | S | 1.21 | 700 | 844 | 1,333,550 | 1.3 M to 1.3 M (-0.05 %) |
Nov 30 2015 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Global Medical ... | Sell | S | 1.20 | 2,600 | 3,120 | 1,334,250 | 1.3 M to 1.3 M (-0.19 %) |
Nov 20 2015 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Sell | S | 1.16 | 100 | 116 | 906,347 | 906.4 K to 906.3 K (-0.01 %) |
Nov 20 2015 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Sell | S | 1.16 | 1,100 | 1,271 | 906,447 | 907.5 K to 906.4 K (-0.12 %) |